Urogen Pharma

URGN · NASDAQ

$35.01+$0.86 (+2.52%)TodayMarket closed ·
Prev close $34.15

Who owns URGN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 46.8% of URGN’s shares.

  • RTW Investments L.P.9.3%
  • BlackRock Institutional Trust Company, N.A.5.4%
  • Morgan Stanley & Co. LLC5.2%
  • Kynam Capital Management LP5.0%
  • Next 6 largest institutions21.9%
  • All other shareholders53.2%
Top institutional holders of URGN
HolderShares% of shares
RTW Investments L.P.4.54M9.33%
BlackRock Institutional Trust Company, N.A.2.62M5.37%
Morgan Stanley & Co. LLC2.56M5.24%
Kynam Capital Management LP2.43M5.00%
Jefferies LLC2.20M4.51%
SG Americas Securities, L.L.C.2.05M4.21%
American Century Investment Management, Inc.1.69M3.46%
Acorn Capital Advisors, LLC1.67M3.43%
Point72 Asset Management, L.P.1.53M3.13%
Frontier Capital Management Company, LLC1.51M3.10%

Largest mutual fund holders

Top mutual fund holders of URGN
HolderShares% of shares
iShares Russell 2000 ETF1.10M2.26%
American Century Small Cap Growth Fund874.98K1.80%
Candriam Equities L Biotechnology610.38K1.25%
Biotech Growth Trust PLC587.03K1.20%
Candriam Equities L Oncology560.35K1.15%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $4.23M (8 trades) of URGN on the open market, with no buys.

Latest URGN insider transactions
InsiderTypeSharesValue
Degnan ChrisOption exercise4.48K—
Degnan ChrisSale2.20K$80.79K
Degnan ChrisOption exercise4.48K—
Schoenberg MarkSale871$37.38K
Smith Jason DrewSale1.52K$64.62K
Schoenberg MarkOption exercise1.67K—
Schoenberg MarkOption exercise1.67K—
Smith Jason DrewOption exercise3.33K—
Smith Jason DrewOption exercise3.33K—
Robinson James A. Jr.Option exercise2.00K—

Short interest

Settled Sep 30, 2026

Shares short
7.77M
Days to cover
9.91
% of shares outstanding
15.94%
Average daily volume
783.55K
Change since last report
+24.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.